Newsroom

Sorted by: Latest
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 24.09.2026 FKUD IE00BD9N0445 121,463.00 GBP 3,723,105.31 30.652  ...
-

Samenvatting: Slechts 4,7% van de financiële instellingen actualiseren continu hun bewaking en controles van naleving naarmate risico verandert, aldus de bevindingen van nieuw onderzoek

PALO ALTO, Calif.--(BUSINESS WIRE)--SymphonyAI, een wereldleider in verticale AI-productplatformen, en AML Intelligence, de toonaangevende bron voor nieuws en inzichten voor de gemeenschap voor naleving van regels tegen financiële criminaliteit, publiceerden vandaag de FinCrime Frontier 2026–27 Report, waarin wordt vastgesteld dat de meeste financiële instellingen nog altijd vertrouwen op periodieke herzieningscycli om met het risico van financiële misdaad om te gaan, zelfs als de dreigingen en...
-

Riassunto: Solo il 4,7% degli istituti finanziari aggiorna a ciclo continuo il monitoraggio e i controlli per la conformità in base all'evoluzione del rischio, secondo una nuova indagine

PALO ALTO, California--(BUSINESS WIRE)--SymphonyAI, leader globale nelle piattaforme di prodotti AI verticali, e AML Intelligence, la principale fonte di notizie e analisi per la comunità che opera per la conformità in materia di reati finanziari, oggi hanno pubblicato il documento FinCrime Frontier 2026–27 Report (Rapporto sulla frontiera dei crimini finanziari 2026–27) da cui si evince che, per gestire il rischio di reati finanziari, la maggior parte degli istituti finanziari fa tuttora affid...
-

Cystar, Incergo and Visual Semiconductor Collaborate on Next-Generation Glasses-Free 3D PC Monitors

FREMONT, Calif. & VIENNA, Austria--(BUSINESS WIRE)--Cystar, Incergo and Visual Semiconductor collaborate on GF3D™ glasses-free 3D PC monitors spanning 4K, 5K, 6K and 8K....
-

Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) in combination with enfortumab vedotin (EV) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or have declined cisplatin-based chemotherapy. The Food and Drug Administration (FDA) grants Priority Review to applications for medicines that, if approved, would offer signific...
-

HighPost Capital Forms Aerospace, Defense, and Cybersecurity Investment Vertical

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--HighPost Capital, LLC (“HighPost”), a leading private investment firm focused on visionary companies and founders, today announced the formation of HighPost Aerospace, Defense, and Cybersecurity, an investment vertical established to invest in high-quality businesses that serve aerospace, defense, cybersecurity, and government missions. In connection with the launch of the vertical, HighPost has assembled a team of seasoned investment professionals and op...
-

The Era of Upright Proton Therapy Has Arrived: Mevion, Leo Cancer Care and RaySearch Bring Clinical Experience to ASTRO 2026

LITTLETON, Mass. & WEST SUSSEX, England & STOCKHOLM--(BUSINESS WIRE)--Upright proton therapy arrives at the American Society for Radiation Oncology 2026 Annual Meeting with more attention on it than any prior year, and there is no more fitting place for that conversation than Boston, where proton therapy began as an idea. This year, that conversation is grounded in something new: patients are being treated upright. Stanford Medicine reported the first patient treated upright on a MEVION S250-FI...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 24.09.2026 FKU IE00B8X9NZ57 181,700.00 GBP 8,097,597.44 44.566  ...
-

Core Scientific Appoints Jay Elms as Chief Commercial Officer

MIAMI--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation (“HDC”), today announced that Jay Elms has joined the Company’s executive team as Chief Commercial Officer. In this role, Elms will be responsible for growing customer relationships and overseeing the customer experience from initial engagement through deployment. “We are excited to welcome Jay to our executive team,” said Adam Sulliva...
-

Vince Holding Corp. Announces Participation in the Noble Capital Markets Emerging Growth Virtual Equity Conference

NEW YORK--(BUSINESS WIRE)--Vince Holding Corp., (Nasdaq: VNCE) (“VNCE” or the “Company”), a global retail platform, today announced that the Company is scheduled to participate in a fireside chat at the Noble Capital Markets Emerging Growth Virtual Equity Conference on Friday, October 2, 2026, at 2:30 PM Eastern Time. A webcast of the presentation will be available in the “Investors” section of the Company’s website at http://investors.vince.com. The webcast will be archived and available on th...